Business Context and Reporting Period
This Form 8-K reports on the 2016 Annual Meeting of Stockholders held by NanoViricides, Inc. on December 11, 2016. The filing details the submission of matters to a vote of security holders, including director elections, executive compensation advisory votes, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Approximately 84.8% of the Company's outstanding voting capital stock was present in person or by proxy. This included 49,274,264 shares of common stock and 3,545,163 shares of Series A Convertible Preferred Stock (which vote at a rate of 9 votes per share). All three proposals were approved by the stockholders:
- Proposal 1 (Election of Directors): Dr. Eugene Seymour (Class II) and Stanley Glick (Class III) were re-elected for two-year terms. Common stock voting support ranged from 95.76% to 95.87%.
- Proposal 2 (Advisory Vote on Executive Compensation): Approved with 95.49% of common stock votes cast in favor.
- Proposal 3 (Ratification of Auditor): Eisner Amper, LLP was ratified as the independent registered public accounting firm for the fiscal year ending June 30, 2017, with 95.57% of common stock votes cast in favor.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the outcomes of the annual meeting.
Investor Verification Checklist
- Verify the re-election of Dr. Eugene Seymour and Stanley Glick to the Board of Directors.
- Confirm the appointment of Eisner Amper, LLP as the independent auditor for the fiscal year ending June 30, 2017.
- Review the Proxy Statement filed on October 28, 2016, for detailed descriptions of the proposals and executive compensation.
- Note that Series A Preferred Shares voted in favor of all proposals but are excluded from the common stock percentage calculations provided in the table.